Promoting Positive Emotional Functioning in Police and Military Populations
1 other identifier
interventional
65
1 country
1
Brief Summary
This study will examine whether actively serving and veteran members of the Canadian Armed Forces (CAF) and Royal Canadian Mounted Police (RCMP) who complete a treatment targeting anhedonia symptoms and amplifying positive emotional processing: 1) experience significant symptom reductions in anxiety, trauma, and depressive symptoms; 2) report increased experience of positive emotions; 3) report improvements to broad functioning and quality of life; and 4) find the treatment to be highly tolerable.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 5, 2023
CompletedFirst Submitted
Initial submission to the registry
September 6, 2023
CompletedFirst Posted
Study publicly available on registry
September 13, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 12, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2025
CompletedJune 4, 2025
May 1, 2025
1.7 years
September 6, 2023
May 29, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Change in depression symptoms
Change in depression symptoms based on the Patient Health Questionnaire-9 (PHQ-9). Scores on this scale range from 0-27, with higher scores indication more severe depression.
6 weeks
Change in anxiety symptoms
Change in anxiety symptoms based on the Overall Anxiety Severity and Impairment Scale (OASIS). Scores on this scale range from 0-20, with higher scores indication more severe anxiety.
6 weeks
Change in PTSD symptoms
Change in PTSD symptom severity based on the Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5). Scores on this scale range from 0-80 with higher scores indicating greater symptom severity.
6 weeks
Secondary Outcomes (4)
Change in positive and negative affect
6 weeks
Change in quality of life
6 weeks
Psychotherapy progress
6 weeks
Treatment acceptability
6 weeks
Study Arms (1)
PVSET
EXPERIMENTALParticipants will receive a course of individual therapy through the Operational Stress Injury Clinic (OSIC) at Deer Lodge Centre. Therapy will consist of a validated treatment protocol known as Positive Valence System Enhancement Treatment for Anxiety and Depression (PVSET), which will consist of psychoeducation and positive activity interventions designed to increase positive emotions, cognitions, and behaviors. Therapy sessions will be facilitated by psychologists, licensed therapists (e.g., MSW, RPN), and/or graduate students in psychology under supervision at the OSIC. PVSET will consist of 6 sessions, each lasting one hour, and will be delivered either virtually or in-person at OSIC depending on patient preference.
Interventions
6, one-hour sessions of individual therapy, consisting of Positive Valence System Enhancement Treatment for Anxiety and Depression (PVSET), which will consist of psychoeducation and positive activity interventions designed to increase positive emotions, cognitions, and behaviors.
Eligibility Criteria
You may qualify if:
- Be an actively serving or veteran member of the CAF and RCMP;
- Have been referred to receive the treatment protocol at the OSIC at Deer Lodge Centre by a doctor or psychologist;
- Have previously participated in at least one evidence-based psychological treatment for depressive, anxiety, or trauma-and-stressor-related condition at OSIC but remain clinically symptomatic;
- Be able to speak, read, and write in English;
- Have no current psychosis, untreated bipolar disorder, or current suicidal ideation with plan and intent;
- Be on a stable medication regime and agree to not make changes for the duration of the treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Deer Lodge Centre
Winnipeg, Manitoba, R3J 0L3, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 6, 2023
First Posted
September 13, 2023
Study Start
September 5, 2023
Primary Completion
May 12, 2025
Study Completion
August 1, 2025
Last Updated
June 4, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share